surfaxin
Surfaxin (Lucinactant) is a medication supplied as a suspension.
Lucinactant · by Lees Pharm Hk
Key facts
- Active ingredient
- Lucinactant
- Form
- Suspension
- Strength
- Lucinactant 8.5ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Lees Pharm Hk
- FDA application
- NDA021746
- Availability
- Discontinued (per FDA)
Dosage forms
Suspension
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- Is there a coupon or discount for Surfaxin?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Surfaxin. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Surfaxin?
- Surfaxin is marketed by Lees Pharm Hk. You can see Lees Pharm Hk's full profile, rating, and other products on pharmaranks.
- Is Surfaxin a brand-name or generic drug?
- Surfaxin is a brand-name product with the active ingredient Lucinactant.
- Is Surfaxin available over the counter?
- No. Surfaxin is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Surfaxin come in?
- Surfaxin is currently marketed as suspension, per the FDA's National Drug Code Directory.
- Is Surfaxin FDA-registered?
- Surfaxin is on record with the U.S. FDA under application number NDA021746. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about LUCINACTANT
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 2 reports naming LUCINACTANT — the active ingredient in Surfaxin, and the FDA flagged 100% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- acute kidney injury1 reports
- apnoea1 reports
- intestinal perforation1 reports
- intraventricular haemorrhage1 reports
- medical device complication1 reports
- necrotising colitis1 reports
- periventricular leukomalacia1 reports
- pneumothorax1 reports
Read these as a signal, not a rate. A report does not mean LUCINACTANT caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
benzamycin
Benzoyl Peroxide and Erythromycin
colazal
Balsalazide Disodium
cuprimine
Penicillamine
mysoline
Primidone
retin-a
Tretinoin
tolak
Fluorouracil
Compare Surfaxin head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
surfaxin
New